Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C
Publication date
2022-06
Authors
van den Broek, Bryan
van der Flier, M.
van de Kar, Nicole C.A.J.
Wetzels, Jack F.M.
de Jonge, Marien I.
de Groot, Ronald
Wijnsma, Kioa L.
Langereis, Jeroen D.
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Nephrology
Citation
van den Broek, B, van der Flier, M, van de Kar, N C A J, Wetzels, J F M, de Jonge, M I, de Groot, R, Wijnsma, K L & Langereis, J D 2022, 'Eculizumab impairs killing of Neisseria meningitidis serogroup B in atypical hemolytic uremic syndrome patients vaccinated with MenB-4C', Kidney International, vol. 101, no. 6, pp. 1293-1295. https://doi.org/10.1016/j.kint.2022.03.010